BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824
489 results:

  • 1. Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies.
    Stummer W; Müther M; Spille D
    Acta Neurochir (Wien); 2024 Apr; 166(1):163. PubMed ID: 38563988
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An adult with recurrent atypical teratoid rhabdoid tumor of the spine.
    Charles AJ; Smith VL; Goodwin CR; Johnson MO
    CNS Oncol; 2024 Jan; 13(1):CNS105. PubMed ID: 38380555
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ALA-rdt in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma.
    Pepper NB; Eich HT; Müther M; Oertel M; Rehn S; Spille DC; Stummer W
    Radiat Oncol; 2024 Jan; 19(1):11. PubMed ID: 38254201
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. smarcb1-Deficient Skull Base Chondrosarcoma with 12p Duplication Presenting as Somatic-Type Malignancy Arising from Metastatic Seminoma.
    Argyris PP; Challa B; Satturwar S; VanKoevering KK; Wakely PE
    Head Neck Pathol; 2024 Jan; 18(1):1. PubMed ID: 38236556
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These tumors Potential Candidates for Immune Checkpoint Blockade?
    Mahajan S; Singh J; Dandapath I; Jha P; Chaturvedi S; Ahuja A; Bhardwaj M; Saran R; Garg A; Sharma MC; Manjunath N; Suri A; Sarkar C; Suri V
    Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):84-95. PubMed ID: 38158760
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Update on Selected High-grade Renal cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas.
    Chen YB
    Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tazemetostat in the therapy of pediatric ini1-negative malignant rhabdoid tumors.
    Vejmelkova K; Pokorna P; Noskova K; Faustmannova A; Drabova K; Pavelka Z; Bajciova V; Broz M; Tinka P; Jezova M; Palova H; Kren L; Valik D; Slaby O; Sterba J
    Sci Rep; 2023 Dec; 13(1):21623. PubMed ID: 38062114
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. SWI/SNF-deficient tumors of the central nervous system: An update.
    Hasselblatt M; Kool M; Frühwald MC
    Clin Neuropathol; 2024; 43(1):2-9. PubMed ID: 37969088
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Longitudinal Natural History Study of Children and Adults with Rare Solid tumors: Initial Results for First 200 Participants.
    Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
    Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant β-Catenin Expression: A Case Expanding the Histologic Spectrum of β-Catenin Activated Gynecologic Neoplasia.
    Xu J; Weisman PS
    Int J Gynecol Pathol; 2024 May; 43(3):302-307. PubMed ID: 37922945
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.
    Lobón-Iglesias MJ; Andrianteranagna M; Han ZY; Chauvin C; Masliah-Planchon J; Manriquez V; Tauziede-Espariat A; Turczynski S; Bouarich-Bourimi R; Frah M; Dufour C; Blauwblomme T; Cardoen L; Pierron G; Maillot L; Guillemot D; Reynaud S; Bourneix C; Pouponnot C; Surdez D; Bohec M; Baulande S; Delattre O; Piaggio E; Ayrault O; Waterfall JJ; Servant N; Beccaria K; Dangouloff-Ros V; Bourdeaut F
    Nat Commun; 2023 Oct; 14(1):6669. PubMed ID: 37863903
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. New classification and approaches to the treatment of schwannomatosis.
    Makashova ES; Zolotova SV; Absalyamova OV; Galkin MV; Petrokovskaya AV; Kozlov AV; Golanov AV
    Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(5):104-109. PubMed ID: 37830475
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Schwannomatosis: a Realm Reborn: year one.
    Planet M; Kalamarides M; Peyre M
    Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Atypical Teratoid/Rhabdoid tumor of the Nervous System in Adults: Location-Related Features and Outcome.
    Corvino S; Del Basso De Caro M; Franca RA; Corazzelli G; Della Monica R; Chiariotti L; Maiuri F
    World Neurosurg; 2023 Nov; 179():e404-e415. PubMed ID: 37659753
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The role of pediatric oncologist in prenatal diagnosis: A 10-year retrospective study at Assistance Publique Hôpitaux de Marseille (AP-HM).
    Min V; Coze S; D'Ercole C; Panait N; Sigaudy S; Aschero A; Zattara H; Bretelle F; Revon-Riviere G; Coze C
    Pediatr Hematol Oncol; 2024; 41(1):30-40. PubMed ID: 37599628
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Constitutional balanced translocations involving smarcb1: A rare cause of rhabdoid tumor predisposition syndrome.
    Blackburn PR; McGee RB; Mostafavi R; Carroll AJ; Mikhail FM; Armstrong GT; Furtado LV; Chiang J; Wheeler DA; Carey SS; Nichols KE; Upadhyaya SA
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23195. PubMed ID: 37548271
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series.
    Stenman A; Falhammar H; Zedenius J; Juhlin CC
    Endocrine; 2023 Dec; 82(3):631-637. PubMed ID: 37535242
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel Strategy Involving High-Dose Chemotherapy with Stem cell Rescue Followed by Intrathecal Topotecan Maintenance Therapy without Whole-Brain Irradiation for Atypical Teratoid/Rhabdoid tumors.
    Yamada A; Kinoshita M; Kamimura S; Jinnouchi T; Azuma M; Yamashita S; Yokogami K; Takeshima H; Moritake H
    Pediatr Hematol Oncol; 2023; 40(7):629-642. PubMed ID: 37519026
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Brain and Spinal Cord tumors of Embryonic Origin.
    Lampros M; Alexiou GA
    Adv Exp Med Biol; 2023; 1405():405-420. PubMed ID: 37452947
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
    Johann PD; Altendorf L; Efremova EM; Holsten T; Steinbügl M; Nemes K; Eckhardt A; Kresbach C; Bockmayr M; Koch A; Haberler C; Antonelli M; DeSisto J; Schuhmann MU; Hauser P; Siebert R; Bens S; Kool M; Green AL; Hasselblatt M; Frühwald MC; Schüller U
    Acta Neuropathol; 2023 Sep; 146(3):527-541. PubMed ID: 37450044
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 25.